Voyager Therapeutics, Inc. (FRA:VT6)
3.562
+0.106 (3.07%)
At close: Dec 5, 2025
Voyager Therapeutics Employees
Voyager Therapeutics had 172 employees as of December 31, 2024. The number of employees increased by 10 or 6.17% compared to the previous year.
Employees
172
Change (1Y)
10
Growth (1Y)
6.17%
Revenue / Employee
€155,178
Profits / Employee
€628,234
Market Cap
204.56M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| SAP SE | 109,121 |
| Siemens Aktiengesellschaft | 318,000 |
| Allianz SE | 156,626 |
| Deutsche Telekom AG | 198,194 |
| Siemens Energy AG | 103,000 |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
| Rheinmetall AG | 28,539 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Voyager Therapeutics News
- 26 days ago - Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates - Nasdaq
- 26 days ago - Voyager Therapeutics (VYGR) Partners with Transition Bio for ALS and FTD Drug Discovery - GuruFocus
- 26 days ago - Voyager Therapeutics GAAP EPS of -$0.47 beats by $0.05, revenue of $13.37M beats by $5.51M - Seeking Alpha
- 26 days ago - Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia - GlobeNewsWire
- 26 days ago - Voyager Reports Third Quarter 2025 Financial and Operating Results - GlobeNewsWire
- 3 months ago - Voyager Therapeutics, Inc. (VYGR) Presents At Citi's Biopharma Back To School Conference Transcript - Seeking Alpha
- 3 months ago - Voyager to Present at Upcoming Investor Conferences - GlobeNewsWire
- 4 months ago - Voyager Reports Second Quarter 2025 Financial and Operating Results - GlobeNewsWire